86034690 - KANNALIFE

Information

• Trademark
• 86034690

• Source

• Serial Number

  86034690

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 12, 2013
  11 years ago

• Transaction Date

  May 11, 2015
  9 years ago

• Status Date

  May 11, 2015
  9 years ago

• Published for Opposition Date

  August 12, 2014
  10 years ago

• Location Date

  October 07, 2014
  10 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  LOOK, JEFFREY J

• Attorney Docket Number

  13026/0010

  Attorney Name

  Brad M. Behar

  Law Office Assigned Location Code

  L80

• Owners

  • KANNALIFE SCIENCES, INC

Case File Statements

• GS0011: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Oxidative Stress Related and Neurodegenerative Diseases; Chemical additives for use in the manufacture of naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals
• GS0051: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Inhalers filled with naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents for epidermis; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations for the treatment and prevention of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations, namely, elixirs for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Sunburn preparations for pharmaceutical purposes; Syringes sold filled with naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Syrups for pharmaceutical purposes for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Therapeutic pharmaceutical for the treatment of Oxidative Stress Related and Neurodegenerative Diseases
• GS0421: Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of Oxidative Stress Related and Neurodegenerative Diseases
• PM0000: KANNA LIFE

Case File Event Statements

• 5/11/2015 - 9 years ago

  21 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/11/2015 - 9 years ago

  20 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 10/7/2014 - 10 years ago

  19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/13/2014 - 10 years ago

  18 - ASSIGNED TO EXAMINER Type: DOCK

• 8/12/2014 - 10 years ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/12/2014 - 10 years ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/11/2014 - 10 years ago

  15 - ASSIGNED TO EXAMINER Type: DOCK

• 7/23/2014 - 10 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/8/2014 - 10 years ago

  13 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/7/2014 - 10 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/10/2014 - 10 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/10/2014 - 10 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/4/2014 - 10 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 5/21/2014 - 10 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/27/2013 - 11 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/27/2013 - 11 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/27/2013 - 11 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/27/2013 - 11 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/21/2013 - 11 years ago

  3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK

• 8/20/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 8/15/2013 - 11 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP